Please use this identifier to cite or link to this item:
https://doi.org/10.1128/AAC.00469-17
DC Field | Value | |
---|---|---|
dc.title | Antimicrobial activity and cell selectivity of synthetic and biosynthetic cationic polymers | |
dc.contributor.author | Venkatesh, M | |
dc.contributor.author | Barathi, V.A | |
dc.contributor.author | Goh, E.T.L | |
dc.contributor.author | Anggara, R | |
dc.contributor.author | Fazil, M.H.U.T | |
dc.contributor.author | Ng, A.J.Y | |
dc.contributor.author | Harini, S | |
dc.contributor.author | Aung, T.T | |
dc.contributor.author | Fox, S.J | |
dc.contributor.author | Liu, S | |
dc.contributor.author | Yang, L | |
dc.contributor.author | Barkham, T.M.S | |
dc.contributor.author | Loh, X.J | |
dc.contributor.author | Verma, N.K | |
dc.contributor.author | Beuerman, R.W | |
dc.contributor.author | Lakshminarayanan, R | |
dc.date.accessioned | 2020-10-23T02:38:52Z | |
dc.date.available | 2020-10-23T02:38:52Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Venkatesh, M, Barathi, V.A, Goh, E.T.L, Anggara, R, Fazil, M.H.U.T, Ng, A.J.Y, Harini, S, Aung, T.T, Fox, S.J, Liu, S, Yang, L, Barkham, T.M.S, Loh, X.J, Verma, N.K, Beuerman, R.W, Lakshminarayanan, R (2017). Antimicrobial activity and cell selectivity of synthetic and biosynthetic cationic polymers. Antimicrobial Agents and Chemotherapy 61 (10). ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.00469-17 | |
dc.identifier.issn | 0066-4804 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/179258 | |
dc.description.abstract | The mammalian and microbial cell selectivity of synthetic and biosynthetic cationic polymers has been investigated. Among the polymers with peptide backbones, polymers containing amino side chains display greater antimicrobial activity than those with guanidine side chains, whereas ethylenimines display superior activity over allylamines. The biosynthetic polymer ε-polylysine (εPL) is noncytotoxic to primary human dermal fibroblasts at concentrations of up to 2,000 μg/ml, suggesting that the presence of an isopeptide backbone has greater cell selectivity than the presence of α-peptide backbones. Both εPL and linear polyethylenimine (LPEI) exhibit bactericidal properties by depolarizing the cytoplasmic membrane and disrupt preformed biofilms. εPL displays broad-spectrum antimicrobial properties against antibiotic-resistant Gram-negative and Gram-positive strains and fungi. εPL elicits rapid bactericidal activity against both Gram-negative and Gram-positive bacteria, and its biocompatibility index is superior to those of cationic antiseptic agents and LPEI. εPL does not interfere with the wound closure of injured rabbit corneas. In a rabbit model of bacterial keratitis, the topical application of εPL (0.3%, wt/vol) decreases the bacterial burden and severity of infections caused by Pseudomonas aeruginosa and Staphylococcus aureus strains. In vivo imaging studies confirm that εPL-treated corneas appeared transparent and nonedematous compared to untreated infected corneas. Taken together, our results highlight the potential of εPL in resolving topical microbial infections. © 2017 Venkatesh et al. | |
dc.publisher | American Society for Microbiology | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | allylamine | |
dc.subject | antiinfective agent | |
dc.subject | aziridine | |
dc.subject | benzalkonium chloride | |
dc.subject | chlorhexidine | |
dc.subject | epsilon polylysine | |
dc.subject | guanidine | |
dc.subject | polyethyleneimine | |
dc.subject | polylysine | |
dc.subject | polymer | |
dc.subject | tobramycin | |
dc.subject | unclassified drug | |
dc.subject | allylamine | |
dc.subject | antiinfective agent | |
dc.subject | antimicrobial cationic peptide | |
dc.subject | aziridine derivative | |
dc.subject | polyethyleneimine | |
dc.subject | polylysine | |
dc.subject | polymer | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | antimicrobial activity | |
dc.subject | Article | |
dc.subject | bacterial keratitis | |
dc.subject | bacterial strain | |
dc.subject | bactericidal activity | |
dc.subject | biocompatibility | |
dc.subject | biofilm | |
dc.subject | cell membrane | |
dc.subject | controlled study | |
dc.subject | cornea | |
dc.subject | cornea injury | |
dc.subject | fibroblast | |
dc.subject | fungus | |
dc.subject | Gram negative bacterium | |
dc.subject | Gram positive bacterium | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | in vivo study | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | Pseudomonas infection | |
dc.subject | Staphylococcus infection | |
dc.subject | wound closure | |
dc.subject | animal | |
dc.subject | Candida albicans | |
dc.subject | candidiasis | |
dc.subject | cell line | |
dc.subject | chemistry | |
dc.subject | disease model | |
dc.subject | drug effect | |
dc.subject | keratitis | |
dc.subject | Leporidae | |
dc.subject | microbial sensitivity test | |
dc.subject | microbiology | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Pseudomonas infection | |
dc.subject | Staphylococcus aureus | |
dc.subject | Staphylococcus infection | |
dc.subject | Allylamine | |
dc.subject | Animals | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Antimicrobial Cationic Peptides | |
dc.subject | Aziridines | |
dc.subject | Candida albicans | |
dc.subject | Candidiasis | |
dc.subject | Cell Line | |
dc.subject | Cell Membrane | |
dc.subject | Disease Models, Animal | |
dc.subject | Fibroblasts | |
dc.subject | Humans | |
dc.subject | Keratitis | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Polyethyleneimine | |
dc.subject | Polylysine | |
dc.subject | Polymers | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Pseudomonas Infections | |
dc.subject | Rabbits | |
dc.subject | Staphylococcal Infections | |
dc.subject | Staphylococcus aureus | |
dc.type | Article | |
dc.contributor.department | MATERIALS SCIENCE AND ENGINEERING | |
dc.contributor.department | MICROBIOLOGY AND IMMUNOLOGY | |
dc.contributor.department | OPHTHALMOLOGY | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1128/AAC.00469-17 | |
dc.description.sourcetitle | Antimicrobial Agents and Chemotherapy | |
dc.description.volume | 61 | |
dc.description.issue | 10 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1128_AAC_00469-17.pdf | 3.02 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License